Nephros Inc. logo

Nephros Inc.

NEPH | NASDAQ
Chart Builder DCF Calculator
$3.25
+$0.08 (+2.52%)
Nov 2, 2026, 12:30 PM ET · Market open

Company Profile

Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.

Key Executives

Name Position
Robert Banks President, Chief Executive Officer & Director
Judy F. Krandel Chief Financial Officer
Brianne McGuire Director of Brand, Marketing & Business Development
Greg Lucas President of Aether Water Systems
Judy Mazzini Controller
Michael Milman Vice President of R&D
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources

Latest SEC Filings

Date Type Title
Sep 16, 2026 SC 13D/A [Amend] Filing
Sep 16, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 16, 2026 4 Filing
Sep 16, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 14, 2026 4 Filing
Aug 10, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jun 12, 2026 4 Filing
Jun 15, 2026 8-K Current Report
View All SEC Filings ➞
Nephros Inc.
Nephros Inc. logo
Country United States
IPO Date Sep 21, 2004
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 36
CEO Robert Banks

Contact Details

380 Lackawanna Place South Orange, New Jersey 07079 United States

Stock Details

Ticker Symbol NEPH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001196298
CUSIP Number 640671400
ISIN Number US6406714005
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.